What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Predicting and preventing clonal evolution in multiple myeloma
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Current research at Weill Cornell and the New York Genome Center
Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma